These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20360595)

  • 1. Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia.
    Luppi P; Powers RW; Verma V; Edmunds L; Plymire D; Hubel CA
    Reprod Sci; 2010 Jul; 17(7):643-52. PubMed ID: 20360595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE.
    Ebner P; Picard F; Richter J; Darrelmann E; Schneider M; Strauer BE; Brehm M
    Rheumatology (Oxford); 2010 Jan; 49(1):63-72. PubMed ID: 19995856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia.
    Massa M; Rosti V; Ramajoli I; Campanelli R; Pecci A; Viarengo G; Meli V; Marchetti M; Hoffman R; Barosi G
    J Clin Oncol; 2005 Aug; 23(24):5688-95. PubMed ID: 16110028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial progenitor cells decrease in patients after endarterectomy.
    Stein A; Montens HP; Steppich B; Busch G; Brandl R; Ott I
    J Vasc Surg; 2008 Nov; 48(5):1217-22. PubMed ID: 18692349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease.
    Powell TM; Paul JD; Hill JM; Thompson M; Benjamin M; Rodrigo M; McCoy JP; Read EJ; Khuu HM; Leitman SF; Finkel T; Cannon RO
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):296-301. PubMed ID: 15569821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of glycemic control on circulating endothelial progenitor cells and arterial stiffness in patients with type 2 diabetes mellitus.
    Yue WS; Lau KK; Siu CW; Wang M; Yan GH; Yiu KH; Tse HF
    Cardiovasc Diabetol; 2011 Dec; 10():113. PubMed ID: 22185563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities.
    Friedrich EB; Walenta K; Scharlau J; Nickenig G; Werner N
    Circ Res; 2006 Feb; 98(3):e20-5. PubMed ID: 16439688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating progenitor and angiogenic cell frequencies are abnormally static over pregnancy in women with preconception diabetes: A pilot study.
    Lima PD; Chen Z; Tayab A; Murphy MS; Pudwell J; Smith GN; Croy BA
    PLoS One; 2017; 12(3):e0172988. PubMed ID: 28278173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.
    Dome B; Timar J; Dobos J; Meszaros L; Raso E; Paku S; Kenessey I; Ostoros G; Magyar M; Ladanyi A; Bogos K; Tovari J
    Cancer Res; 2006 Jul; 66(14):7341-7. PubMed ID: 16849585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced levels of circulating progenitor cells in juvenile idiopathic arthritis are counteracted by anti TNF-α therapy.
    Martini G; Biscaro F; Boscaro E; Calabrese F; Lunardi F; Facco M; Agostini C; Zulian F; Fadini GP
    BMC Musculoskelet Disord; 2015 Apr; 16():103. PubMed ID: 25925313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
    Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
    Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.
    Grundmann F; Scheid C; Braun D; Zobel C; Reuter H; Schwinger RH; Müller-Ehmsen J
    Clin Res Cardiol; 2007 Sep; 96(9):621-7. PubMed ID: 17676354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure.
    Fritzenwanger M; Lorenz F; Jung C; Fabris M; Thude H; Barz D; Figulla HR
    Eur J Med Res; 2009 Mar; 14(3):113-7. PubMed ID: 19380281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverse correlation between circulating endothelial progenitor cells with CD34+CD133+ and the severity of coronary atherosclerosis assessed by Syntax score.
    Chi J; Hong X; Wang Y; Zhao J; Yang W
    Am J Med Sci; 2014 Jun; 347(6):457-62. PubMed ID: 24335569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma.
    Kleinman ME; Tepper OM; Capla JM; Bhatt KA; Ceradini DJ; Galiano RD; Blei F; Levine JP; Gurtner GC
    Lymphat Res Biol; 2003; 1(4):301-7. PubMed ID: 15624558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD-34
    Brown N; Khan F; Alshaikh B; Berka N; Liacini A; Alawad E; Yusuf K
    Pregnancy Hypertens; 2019 Apr; 16():42-47. PubMed ID: 31056159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between circulating endothelial progenitor cells and coronary collateral formation.
    Tokgözoğlu L; Yorgun H; Gürses KM; Canpolat U; Ateş AH; Tülümen E; Kaya EB; Aytemir K; Kabakçı G; Tuncer M; Oto A
    Atherosclerosis; 2011 Dec; 219(2):851-4. PubMed ID: 21943873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants.
    Borghesi A; Massa M; Campanelli R; Garofoli F; Longo S; Cabano R; Mazzucchelli I; Tzialla C; Gavilanes AW; Gazzolo D; Manzoni P; Bollani L; Spinillo A; Rosti V; Stronati M
    Int J Immunopathol Pharmacol; 2013; 26(3):809-16. PubMed ID: 24067483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial cells (EC) and endothelial precursor cells (EPC) kinetics in hematological patients undergoing chemotherapy or autologous stem cell transplantation (ASCT).
    Kideryová L; Pytlík R; Benešová K; Veselá R; Karban J; Rychtrmocová H; Goettsch W; Morawietz H; Trněný M
    Hematol Oncol; 2010 Dec; 28(4):192-201. PubMed ID: 21136582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.
    Golab-Janowska M; Paczkowska E; Machalinski B; Kotlega D; Meller A; Safranow K; Wankowicz P; Nowacki P
    Curr Neurovasc Res; 2019; 16(1):19-26. PubMed ID: 30706812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.